News Desk — April 5, 2018 at 4:01 pm — Updated: April 5, 2018 at 4:01 pm

Hopes rise for Shire sale as Takeda CEO discusses case for deal


LONDON (Reuters) – Expectations that Takeda Pharmaceutical will bid for London-listed rare disease specialist Shire before an April 25 deadline rose on Thursday after comments from the head of the Japanese drugmaker on the merits of a deal.

Leave A Comment Using Facebook (Website Comment Form Below)

Use the form below to post a comment via facebook

Leave a Reply

69 queries in 1.033 seconds.